Meridiem Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,221
Closed -$351K 74
2023
Q4
$351K Buy
+3,221
New +$334K 0.01% 39
2021
Q1
Sell
-379
Closed -$30K 96
2020
Q4
$30K Buy
+379
New +$29K ﹤0.01% 83

Other funds holding MRK

Meridiem Investment Management's MRK Position: Q1 2024 in Review

Meridiem Investment Management sold out of Merck (MRK) in Q1 2024, closing a stake of 3,221 shares — an estimated $351K sold.

Meridiem Investment Management first reported a position in MRK in Q4 2020 and held it in 2 quarters. The position peaked at $351K in Q4 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Meridiem Investment Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Meridiem Investment Management sold 3,221 Merck shares in Q1 2024, an estimated $351K.
  • Meridiem Investment Management first reported a position in Merck in Q4 2020 and held it in 2 quarters.
  • Meridiem Investment Management's Merck position peaked at $351K in Q4 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Meridiem Investment Management's 13F filing for Q1 2024, filed 10 May 2024.